Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
_256_384.jpg)
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
Biocorp will receive an initial milestone payment this year
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Subscribe To Our Newsletter & Stay Updated
